GXQ · Class II · 21 CFR 882.5910

FDA Product Code GXQ: Dura Substitute

Leading manufacturers include Synthes USA Products, LLC, Helios Biomedical, Inc. and Collagen Matrix, Inc..

43
Total
43
Cleared
146d
Avg days
1995
Since
Growing category - 2 submissions in the last 2 years vs 1 in the prior period
Consistent review times: 153d avg (recent)

FDA 510(k) Cleared Dura Substitute Devices (Product Code GXQ)

43 devices
1–24 of 43

About Product Code GXQ - Regulatory Context

510(k) Submission Activity

43 total 510(k) submissions under product code GXQ since 1995, with 43 receiving FDA clearance (average review time: 146 days).

Submission volume has increased in recent years - 2 submissions in the last 24 months compared to 1 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

FDA review times for GXQ submissions have been consistent, averaging 153 days recently vs 146 days historically.

GXQ devices are reviewed by the Neurology panel. Browse all Neurology devices →